These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8647159

  • 1. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I, Erny K, Acha-Orbea H, Diggelmann H.
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [Abstract] [Full Text] [Related]

  • 2. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 3. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F, Wirth S, Maillard I, Valsesia S, Acha-Orbea H, Diggelmann H.
    J Virol; 2001 Aug 15; 75(16):7453-61. PubMed ID: 11462017
    [Abstract] [Full Text] [Related]

  • 4. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Eur J Immunol; 1994 Jul 15; 24(7):1612-9. PubMed ID: 7913038
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 8. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1996 Jan 15; 215(2):113-23. PubMed ID: 8560758
    [Abstract] [Full Text] [Related]

  • 9. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H.
    Eur J Immunol; 1995 Mar 15; 25(3):857-62. PubMed ID: 7705418
    [Abstract] [Full Text] [Related]

  • 10. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R, Wang H, Bluethmann H, Iglesias A, Wei WZ.
    Cancer Res; 1994 Mar 15; 54(6):1529-35. PubMed ID: 8137259
    [Abstract] [Full Text] [Related]

  • 11. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
    Nakano H, Yoshimoto T, Nariuchi H, Kakiuchi T, Matsuzawa A.
    Cell Immunol; 1996 Mar 15; 168(2):281-90. PubMed ID: 8640876
    [Abstract] [Full Text] [Related]

  • 16. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Virology; 1996 Sep 15; 223(2):387-91. PubMed ID: 8806576
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA, Lees RK, Held W, MacDonald HR.
    Eur J Immunol; 1995 Sep 15; 25(9):2632-7. PubMed ID: 7589137
    [Abstract] [Full Text] [Related]

  • 19. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
    Wang H, Gill RF, Lichlyter D, Iglesias A, Bluethmann H, Wei WZ.
    Eur J Immunol; 1994 Dec 15; 24(12):2950-6. PubMed ID: 7805721
    [Abstract] [Full Text] [Related]

  • 20. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW, Bogatzki LY, Pullen AM.
    Virology; 1997 Feb 17; 228(2):161-70. PubMed ID: 9123822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.